Single Cell Multiomics Market Report 2026

Single Cell Multiomics Market Overview

• Single Cell Multiomics market size has reached to $4.85 billion in 2025 • Expected to grow to $13 billion in 2030 at a compound annual growth rate (CAGR) of 21.7% • Growth Driver: Growth Of Precision Medicine Boosts Single Cell Multiomics Market • Market Trend: Advancements In Single-Cell Multiomics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single Cell Multiomics Market?

Single-cell multiomics is an advanced approach that integrates multiple types of molecular data, such as genomics, transcriptomics, proteomics, and metabolomics, at the individual cell level. This method provides a comprehensive view of cellular heterogeneity and function, enabling more precise insights into complex biological processes and disease mechanisms. The main types in the single cell multiomics market are single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. Single cell genomics refers to the study and analysis of the complete set of genetic material (DNA) within an individual cell. The various techniques include single cell isolation and dispensing and single cell analysis, and several applications including oncology, cell biology, neurology, immunology, and stem cell research. The different end users encompass academic institutes, contract research organizations, and pharmaceutical and biotech companies.

What Is The Single Cell Multiomics Market Growth Forecast?

The single cell multiomics market size is expected to see exponential growth in the next few years. It will grow to $13 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to rising demand for precision medicine applications, increasing adoption in clinical research workflows, expansion of multiomics data integration platforms, growing pharmaceutical research investments, continuous improvements in analytical sensitivity. Major trends in the forecast period include increasing adoption of integrated multiomics platforms, rising demand for high-resolution single-cell analysis, growing use of AI-driven data interpretation tools, expansion of multi-modal cellular profiling techniques, enhanced focus on cellular heterogeneity insights.

Global Single Cell Multiomics Market Segmentation

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics 2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis 3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research 4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies Subsegments: 1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms 2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms 3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools 4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

What Is The Driver Of The Single Cell Multiomics Market?

The increasing demand for precision medicine is expected to propel the growth of the single cell multiomics market going forward. Precision medicine refers to a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient. The rise in precision medicine is fueled by advancements in genomic research, enhanced data analysis capabilities, and a heightened understanding of personalized healthcare advantages. Single-cell multiomics provides detailed insights into cellular heterogeneity and molecular mechanisms, enabling the development of highly personalized treatments tailored to individual patients' unique cellular profiles. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), in 2023, a U.S.-based professional organization, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines, about 38% of all newly approved therapeutic molecular entities. Therefore, the increasing demand for precision medicine is driving the growth of the single cell multiomics industry.

Key Players In The Global Single Cell Multiomics Market

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Global Single Cell Multiomics Market Trends and Insights

Major companies operating in the single cell multiomics market are developing single-cell multiomics tests to enhance the accuracy and resolution of cellular analysis. Single-cell multiomics tests enable researchers to better understand complex biological processes, identify rare cell populations, and tailor precision medicine approaches by integrating comprehensive molecular data from individual cells. For instance, in June 2024, Mission Bio, a US-based biotechnology company, launched Tapestri Single-cell Multiple Myeloma Multiomics Solution, which enables comprehensive profiling of multiple myeloma at single-cell resolution. This solution enables translational researchers and drug developers to fully dissect the molecular and cellular landscape during myeloid progression, understand therapy resistance, and identify drivers of disease evolution from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

What Are Latest Mergers And Acquisitions In The Single Cell Multiomics Market?

In July 2024, Illumina, a US-based provider of DNA sequencing, array-based technologies, and genomic informatics solutions, acquired Fluent BioSciences for an undisclosed amount. With this acquisition, Illumina aimed to enhance its single-cell and multiomics capabilities, enabling researchers to perform high-throughput, scalable single-cell analysis with greater accessibility and reduced complexity. Fluent Biosciences is a US-based company developing innovative single-cell technologies (notably its PipSeq™ V assay) that simplify single-cell analysis by eliminating the need for complex instrumentation and microfluidic consumables, thereby expanding applicability to a broader range of laboratories.

Regional Outlook

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Single Cell Multiomics Market?

The single cell multiomics market consists of revenues earned by entities by providing services such as single-cell RNA sequencing, cellular imaging, and integrated multiomics solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The single cell multiomics market also includes sales of single cell isolation instruments, library preparation kits, and proteomics assays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Single Cell Multiomics Market Report 2026?

The single cell multiomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single cell multiomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.